Abstract
Pharmacovigilance plays a pivotal role in ensuring drug safety, especially as pharmaceutical products are widely used across diverse patient populations. The discipline encompasses the detection, assessment, understanding, and prevention of adverse drug reactions (ADRs) or any other drug-related problems. This article provides a comprehensive review of the role of pharmacovigilance in maintaining drug safety. We explore various methodologies employed in pharmacovigilance, including spontaneous reporting systems, risk assessment tools, and regulatory frameworks. Furthermore, the article examines the evolving challenges in the field, including global harmonization of pharmacovigilance efforts and the impact of digital health technologies on drug safety monitoring. Through this review, we aim to underline the importance of pharmacovigilance as an essential component of public health safety and therapeutic decision-making.
All articles published in the American Journal of Pharmaceutics are open access and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows users to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given, a link to the license must be provided, and any changes must be indicated.
-
Authors retain full copyright of their work.
-
The journal does not restrict reuse of content, provided proper citation of the original publication is made.